INBIOGEN Co., Ltd. (KRX:101140)

INBIOGEN Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,339	901.7	5,716	6,089	9,290	23,152
Cash & Short-Term Investments	2,339	901.7	5,716	6,089	9,290	23,152
Cash Growth	-14.60%	-84.23%	-6.12%	-34.45%	-59.88%	-70.71%
Accounts Receivable	4,482	4,162	3,285	4,182	5,494	6,233
Other Receivables	59.35	137.41	143.02	87.24	155.77	302.59
Receivables	4,541	4,300	3,428	4,269	5,650	6,575
Inventory	-	29.93	111.03	876.6	1,532	1,482
Prepaid Expenses	1.56	6.97	9.35	18.85	43.3	83.18
Other Current Assets	13.46	82.93	15.4	77.87	218.98	609.84
Total Current Assets	6,896	5,321	9,280	11,332	16,733	31,902
Property, Plant & Equipment	-	-	1,186	2,595	3,691	4,361
Long-Term Investments	135,894	150,581	148,404	126,236	116,798	232,141
Other Intangible Assets	109.68	-	190.82	649.38	510.97	462.59
Long-Term Accounts Receivable	3,609	3,784	2,940	2,130	3,486	4,363
Other Long-Term Assets	372.01	306.58	729.27	2,762	3,064	1,245
Total Assets	146,879	159,993	162,730	145,704	144,284	274,475

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	545.01	273.03	684.25	317.9	308.8	646.11
Accrued Expenses	225.51	286.38	403.38	401.12	346.01	605.07
Short-Term Debt	3,500	500	-	-	934.13	11,631
Current Portion of Leases	249.91	241.4	227.03	263.69	286.9	714.79
Other Current Liabilities	502.78	560.79	802.02	1,131	1,934	14,246
Total Current Liabilities	5,023	1,862	2,117	2,114	3,810	27,843
Long-Term Leases	299.19	426.36	667.76	329.57	553.26	1,064
Long-Term Deferred Tax Liabilities	-	-	-	-	-	16,953
Other Long-Term Liabilities	54.27	61.91	109.11	176.96	484.99	660.23
Total Liabilities	5,377	2,350	2,894	2,621	4,848	46,521

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	5,022	5,022	5,022	5,022	70,442	26,698
Additional Paid-In Capital	136,123	136,123	136,123	136,123	141,607	139,272
Retained Earnings	2,301	18,455	20,070	3,935	-102,829	14,389
Treasury Stock	-2,448	-2,448	-2,448	-2,448	-2,385	-2,385
Comprehensive Income & Other	503.41	490.51	1,069	449.87	48.4	48.4
Total Common Equity	141,502	157,643	159,836	143,083	106,884	178,022
Shareholders' Equity	141,503	157,644	159,837	143,083	139,436	227,954
Total Liabilities & Equity	146,879	159,993	162,730	145,704	144,284	274,475

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4,049	1,168	894.79	593.26	1,774	13,410
Net Cash (Debt)	-1,710	-266.07	4,821	5,496	7,515	9,742
Net Cash Growth	-	-	-12.27%	-26.87%	-22.85%	-86.88%
Net Cash Per Share	-	-	482.88	645.77	2072.63	3260.05
Filing Date Shares Outstanding	-	9.98	9.98	9.98	6.99	2.62
Total Common Shares Outstanding	-	9.98	9.98	9.98	6.99	2.62
Working Capital	1,872	3,460	7,164	9,218	12,924	4,059
Book Value Per Share	-	15788.35	16007.99	14330.10	15287.73	68023.15
Tangible Book Value	141,393	157,643	159,645	142,433	106,373	177,560
Tangible Book Value Per Share	-	15788.35	15988.88	14265.07	15214.65	67846.39
Machinery	-	-	566.08	1,067	1,123	1,073

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error